Financial Trends -- 9/10

NVIDIA delivered extraordinary financial performance in CY2025: $215.9B in revenue (+66% YoY), $96.6B in free cash flow, and re-accelerating revenue growth at massive scale. Margins compressed temporarily from the H20 write-down and Blackwell ramp but have recovered to 75% GAAP GM. Weight: 25%
FY2025 Revenue
$215.9B
CY2025, +66% YoY
Q4 CY2025 Revenue
$68.1B
+73% YoY, re-accelerating
CY2025 FCF
$96.6B
45% of revenue
GAAP Gross Margin
75.0%
Q4 CY2025, recovered from 60.5% trough
Revenue (quarterly)
MetricQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
Revenue ($B)$13.5B$18.1B$22.1B$26.0B$30.0B$35.1B$39.3B$44.1B$46.7B$57.0B$68.1B
YoY Growth+101%+206%+265%+262%+122%+94%+78%+69%+56%+62%+73%
TrendAccelAccelAccelPeakDecelDecelDecelDecelDecelRe-accelRe-accel
Key trends
Source: Daloopa. All figures linked to source records.

GAAP Gross Margin (quarterly)
MetricQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
GAAP GM (%)$70.1%$74.0%$76.0%$78.4%$75.1%$74.6%$73.0%$60.5%$72.4%$73.4%$75.0%
YoY bps chg+940+1020+730+510+500+60-300-1790-270-120+200
Key trends
Source: Daloopa

Operating Income and Margin (quarterly)
MetricQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
Op Income ($B)$13.6B$16.9B$18.6B$21.9B$24.0B$21.6B$28.4B$36.0B$44.3B
Op Margin61.6%64.9%62.1%62.3%61.1%49.1%60.8%63.2%65.0%
Key trends
Source: Daloopa

Free Cash Flow (quarterly)
MetricQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
FCF ($B)$6.0B$7.0B$11.2B$14.9B$13.5B$16.8B$15.5B$26.1B$13.5B$22.1B$34.9B
YoY % chg+545%+479%+535%+464%+123%+138%+38%+75%
Key trends
Source: Daloopa

GAAP Diluted EPS (quarterly)
MetricQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026
GAAP EPS$2.48$3.71$4.93$5.98$0.67$0.78$0.89$0.76$1.08$1.30$1.76
Key trends
Source: Daloopa

5-Year Annual Series
MetricCY2021CY2022CY2023CY2024CY2025
Revenue ($B)$26.9B$27.0B$60.9B$130.5B$215.9B
Op Income ($B)$10.0B$4.2B$33.0B$81.5B$130.4B
Op Margin37.3%15.7%54.1%62.4%60.4%
FCF ($B)$8.0B$3.8B$26.9B$60.7B$96.6B
GAAP Diluted EPS$3.85$1.74$11.93$2.94$4.90
Non-GAAP GM66.8%59.2%73.8%75.5%71.3%
Key trends
Source: Daloopa

Street Consensus Estimates
MetricFY2027E (CY2026E)FY2028E (CY2027E)
Revenue~$313B~$420B+
EPS (GAAP)~$5.72~$8.30
Avg. Price Target$266 (38 analysts)
Consensus RatingStrong Buy

Score rationale

Revenue growth has re-accelerated to +73% YoY at $68B quarterly scale. Margins compressed temporarily from the H20 write-down and Blackwell ramp costs but have recovered to 75% GAAP GM. FCF of $96.6B annualized is extraordinary. Share count is modestly declining. The only knock is that margins peaked at 78.4% in Q1 CY2024 and are now at 75%, a ~340bps compression reflecting new product ramp and China disruption. Revenue growth re-acceleration at scale offsets the margin moderation. Score: 9/10 (not 10 because margins are net compressing YoY from 2024 peaks, preventing the "expanding 100+bps" criteria).


Data sourced from Daloopa, company filings, and sell-side consensus estimates.